XML 72 R55.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
12 Months Ended
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Activity in Common Stock and Treasury Stock Share

Activity in common stock and treasury stock shares are as follows:

 

 

Common Stock

 

 

Treasury Stock

 

 

Treasury stock held for deferred compensation

 

Balances as of September 30, 2021

 

 

72,960

 

 

 

(9,702

)

 

 

(167

)

Purchase of treasury stock

 

 

 

 

 

(4,123

)

 

 

 

Sales of treasury stock

 

 

 

 

 

468

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

150

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

(3

)

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

31

 

Balances as of September 30, 2022

 

 

72,960

 

 

 

(13,207

)

 

 

(139

)

 

 

 

 

 

 

 

 

 

Balances as of September 30, 2022

 

 

72,960

 

 

 

(13,207

)

 

 

(139

)

Purchase of treasury stock

 

 

 

 

 

(1,060

)

 

 

 

Sales of treasury stock

 

 

 

 

 

1,009

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

188

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

(2

)

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

86

 

Balances as of September 30, 2023

 

 

72,960

 

 

 

(13,070

)

 

 

(55

)

 

 

 

 

 

 

 

 

 

Balances as of September 30, 2023

 

 

72,960

 

 

 

(13,070

)

 

 

(55

)

Purchase of treasury stock

 

 

 

 

 

(2,236

)

 

 

 

Sales of treasury stock

 

 

 

 

 

1,360

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

159

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

(1

)

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

11

 

Balances as of September 30, 2024

 

 

72,960

 

 

 

(13,787

)

 

 

(45

)

Summary of Activity for RSUs

A summary of the activity for RSUs:

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

Balance at September 30, 2023

 

 

177

 

 

$

93.46

 

Granted

 

 

178

 

 

 

139.04

 

Vested

 

 

(30

)

 

 

88.97

 

Forfeited

 

 

(7

)

 

 

149.02

 

Balance at September 30, 2024

 

 

318

 

 

$

118.19

 

Stock-based Compensation Expense Recognized

Stock-based compensation expense recognized was as follows:

 

 

Year Ended September 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Employee stock-based compensation expense

 

$

33,052

 

 

$

23,958

 

 

$

20,109

 

Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Assumptions Used in Estimate of Fair Value of Stock Option Awards

The fair value of options granted is estimated as of the grant date using the Black-Scholes-Merton option-valuation model using the assumptions in the following table. Woodward calculates the expected term, which represents the average period of time that stock options granted are expected to be outstanding, based upon historical experience of plan participants. Expected volatility is based on historical volatility using daily stock price observations. The estimated dividend yield is based upon Woodward’s historical dividend practice and the market value of its common stock. The risk-free rate is based on the U.S. treasury yield curve, for periods within the contractual life of the stock option, at the time of grant.

 

 

Year Ended September 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Weighted-average exercise price per share

 

$

137.36

 

 

$

84.84

 

 

$

115.3

 

Expected term (years)

 

 

 

6.6

 

-

 

8.7

 

 

 

 

6.6

 

-

 

8.8

 

 

 

 

6.6

 

-

 

8.7

 

Estimated volatility

 

 

 

35.0

%

-

 

37.6

%

 

 

 

34.7

%

-

 

37.6

%

 

 

 

33.8

%

-

 

36.4

%

Estimated dividend yield

 

 

 

0.7

%

-

 

0.7

%

 

 

 

0.7

%

-

 

0.9

%

 

 

 

0.6

%

-

 

0.8

%

Risk-free interest rate

 

 

 

4.2

%

-

 

4.4

%

 

 

 

3.4

%

-

 

4.4

%

 

 

 

1.1

%

-

 

3.5

%

Weighted Average Grant Date Fair Value of Options Granted

The weighted average grant date fair value of options granted follows:

 

 

Year Ended September 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Weighted-average grant date fair value of options

 

$

58.34

 

 

$

34.19

 

 

$

41.78

 

Summary of Activity for Stock Option Awards

The following is a summary of the activity for stock option awards during the fiscal year ended September 30, 2024:

 

 

Number of options

 

 

Weighted-
Average Exercise
Price Per Share

 

Balance at September 30, 2023

 

 

4,842

 

 

$

80.48

 

Granted

 

 

87

 

 

 

137.36

 

Exercised

 

 

(1,340

)

 

 

69.23

 

Forfeited

 

 

(11

)

 

 

96.82

 

Balance at September 30, 2024

 

 

3,578

 

 

$

86.03

 

 

Changes in Non-vested Stock Options

Changes in non-vested stock options during the fiscal year ended September 30, 2024 were as follows:

 

 

Number of options

 

 

Weighted-
Average Grant
Date Fair Value
Per Share

 

Balance at September 30, 2023

 

 

1,393

 

 

$

33.96

 

Granted

 

 

87

 

 

 

58.34

 

Vested

 

 

(572

)

 

 

32.36

 

Forfeited

 

 

(10

)

 

 

37.76

 

Balance at September 30, 2024

 

 

898

 

 

$

37.30

 

Stock Options Vested, or Expected to Vest and Exercisable

Information about stock options that have vested, or are expected to vest, and are exercisable at September 30, 2024 was as follows:

 

 

Number of options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Life in Years

 

 

Aggregate
Intrinsic
Value

 

Options outstanding

 

 

3,578

 

 

$

86.03

 

 

 

5.3

 

 

$

305,872

 

Options vested and exercisable

 

 

2,680

 

 

 

82.14

 

 

 

4.5

 

 

 

239,541

 

Options vested and expected to vest

 

 

3,557

 

 

 

85.91

 

 

 

5.2

 

 

 

304,515

 

Other Stock Option Information

Other information follows:

 

 

Year Ended September 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Total fair value of stock options vested

 

$

18,527

 

 

$

24,388

 

 

$

18,945

 

Total intrinsic value of options exercised

 

 

115,198

 

 

 

67,203

 

 

 

32,709

 

Cash received from exercises of stock options

 

 

89,875

 

 

 

50,749

 

 

 

21,897

 

Excess tax benefit realized from exercise of stock options

 

 

17,939

 

 

 

12,595

 

 

 

6,472

 

Performance Restricted Stock Units [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Assumptions to Value PSUs Granted

The fair value of the PSUs for the November 2023 grant was determined based upon a Monte Carlo valuation method. The assumptions used in the Monte Carlo method to value the PSUs granted, which includes the grant date fair value outcome from the Monte Carlo method, were as follows:

 

 

September 30, 2024

 

Expected volatility

 

 

30.2

%

Risk free interest rate

 

 

4.5

%

Expected life

 

3 years

 

Grant date fair value

 

$

146.47

 

Summary of Activity for PSUs

A summary of the activity for PSUs:

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

Beginning balance

 

 

 

 

$

 

Granted

 

 

66

 

 

 

146.47

 

Forfeited

 

 

(4

)

 

 

146.47

 

Ending balance

 

 

62

 

 

$

146.47